Bioengineered E. coli bacteria can now produce rhododendron-derived drugs

Post author:admin
Post published: February 17, 2026
Post category:uncategorized

Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Organon and Sempre Health announce collaboration on new service to help eligible patients save money and stay on their medication as prescribed

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer

Cellular senescence drives progression of spinal disc degeneration and pain

Helpful Links

Subscribe To Us